Conversely, inadequate WNT inhibition from mutations or deletions in the sclerostin-encoding SOST results in high bone mass phenotypes sclerosteosis (MIM 269500) and van Buchem disease (MIM 239100), respectively (48, 49). The gene discussed is SOST; the disease is hyperostosis corticalis generalisata.